标题
Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 14, Issue 2, Pages 281-294
出版商
Informa Healthcare
发表日期
2014-12-06
DOI
10.1517/14740338.2015.988137
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Case series: extrapyramidal symptoms associated with use of aripiprazole in older adults
- (2015) Eileen B. Sweeney et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Long-Acting Versus Standard Non-Ergot Dopamine Agonists in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials
- (2014) Chang-Qing Zhou et al. CNS Neuroscience & Therapeutics
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience
- (2013) M. Zibetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson’s disease
- (2013) Nir Giladi et al. JOURNAL OF NEURAL TRANSMISSION
- Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care
- (2013) A. Antonini et al. JOURNAL OF NEURAL TRANSMISSION
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
- (2013) Stewart A. Factor et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease
- (2013) Ramiro González-Aparicio et al. NEUROBIOLOGY OF DISEASE
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia
- (2013) Yu-han Zhang et al. NEUROSCIENCE LETTERS
- Risk of neutropenia in a clozapine-treated elderly population
- (2013) Melanie D. Guenette et al. SCHIZOPHRENIA RESEARCH
- Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
- (2012) C. Moreau et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)
- (2012) P. A. LeWitt et al. NEUROLOGY
- Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial
- (2012) O. Rascol et al. PARKINSONISM & RELATED DISORDERS
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
- (2011) Andrew Lees et al. MOVEMENT DISORDERS
- Pulsatile or continuous dopaminomimetic strategies in Parkinson's disease
- (2011) Daniela Calandrella et al. PARKINSONISM & RELATED DISORDERS
- Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study
- (2011) Emmanuelle Pourcher et al. PARKINSONISM & RELATED DISORDERS
- Modulation of the striato-pallidal pathway by adenosine A2a receptors depends on dopaminergic striatal input
- (2010) Enrique Querejeta et al. BRAIN RESEARCH
- Effect of histamine H2receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease
- (2010) Tom H. Johnston et al. MOVEMENT DISORDERS
- Homeostatic changes of the endocannabinoid system in Parkinson's disease
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease
- (2010) P. Stathis et al. MOVEMENT DISORDERS
- Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets
- (2010) Louisa Clare Johnston et al. MOVEMENT DISORDERS
- Age of Parkinson's disease onset as a predictor for the development of dyskinesia
- (2010) Stephen Ku et al. MOVEMENT DISORDERS
- Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study
- (2010) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias
- (2009) C. G. Bachmann et al. EUROPEAN JOURNAL OF NEUROLOGY
- Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study
- (2009) Giuseppe Meco et al. JOURNAL OF NEURAL TRANSMISSION
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
- Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- Molecular mechanisms underlying levodopa-induced dyskinesia
- (2008) Paolo Calabresi et al. MOVEMENT DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now